Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate Ketamine for the Treatment of Rett Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03633058
Recruitment Status : Completed
First Posted : August 16, 2018
Last Update Posted : April 22, 2022
Sponsor:
Collaborator:
Vanderbilt University Medical Center
Information provided by (Responsible Party):
Rett Syndrome Research Trust

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 8, 2021
Actual Study Completion Date : November 22, 2021